KANDERS WARREN B Insider Trading Activity

Average Profitability
10.98%
Insider Buys Quantity
13
Insider Buys Sum
$22.04M
Insider Sells Quantity
56
Insider Sells Sum
$154.81M

Insider Activity of KANDERS WARREN B

According to the SEC Form 4 filings, KANDERS WARREN B, being in a position of

  1. CEO AND CHAIRMAN at Cadre Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2393941 share for $87.04M,
    over all time since 2022-12-07, has bought 0 shares, and sold 6530457 shares for $202.08M.
  2. Executive Chairman at Clarus Corporation,
    оver the last 12 months, has bought 300399 shares for $975,377, and sold 0 shares,
    over all time since 2007-11-15, has bought 4278987 shares for $23.01M, and sold 3307122 shares for $25.22M.

Biography of KANDERS WARREN B

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $975,377418
Sells
 $87,037,9491882

Comparison of Insiders on Amount of Buys and Sells

2026-02-17SaleADMA Biologics, Inc.
ADMA
President and CEO
21,000
0.0089%
$16.08$337,680-0.81%
2026-02-17SaleAlignment Healthcare, Inc.
ALHC
President
30,000
0.015%
$20.63$618,990-0.21%
2026-02-17SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
2,041
0.0015%
$331.96$677,532+0.2%
2026-02-17SaleAtkore Inc.
ATKR
Pres. Safety & Infrastructure
1,000
0.0029%
$65.78$65,780+1.06%
2026-02-17SaleAura Biosciences, Inc.
AURA
Senior Vice President, Finance
8,549
0.013%
$5.06$43,258+3.75%
2026-02-17SaleAura Biosciences, Inc.
AURA
See Remarks
12,079
0.0183%
$5.05$60,999+3.96%
2026-02-17SaleAura Biosciences, Inc.
AURA
Chief Technology Officer
15,890
0.0241%
$5.05$80,245+3.96%
2026-02-17SaleAura Biosciences, Inc.
AURA
Chief Medical Officer
20,401
0.031%
$5.06$103,229+3.75%
2026-02-17SaleAura Biosciences, Inc.
AURA
See Remarks
47,648
0.0723%
$5.06$241,099+3.75%
2026-02-17SaleAeroVironment, Inc.
AVAV
director
500
0.001%
$254.95$127,475+3.15%
2026-02-17SaleAvidbank Holdings, Inc.
AVBH
director
5,076
0.0585%
$30.17$153,153-0.37%
2026-02-17PurchaseByline Bancorp, Inc.
BY
General Counsel
750
0.0016%
$33.13$24,847+0.06%
2026-02-17SaleCentral Garden & Pet Company
CENT
President, Pet Consumer Prod
5,000
0.0072%
$34.75$173,761+11.1%
2026-02-17PurchaseCineverse Corp.
CNVS
Chief Motion Pictures Officer
30,000
0.1131%
$2.00$60,000+35.5%
2026-02-17PurchaseCineverse Corp.
CNVS
CFO
35,000
0.132%
$2.00$70,000+35.5%
2026-02-17PurchaseCineverse Corp.
CNVS
CEO and Chairman
75,000
0.2828%
$2.00$150,000+35.5%
2026-02-17PurchaseCineverse Corp.
CNVS
Chief People Officer
25,000
0.0943%
$2.00$50,000+35.5%
2026-02-17PurchaseCineverse Corp.
CNVS
Pres Tech/Chief Product Off
37,500
0.1414%
$2.00$75,000+35.5%
2026-02-17PurchaseCineverse Corp.
CNVS
CLO, Secretary and Sr Advisor
30,000
0.1131%
$2.00$60,000+35.5%
2026-02-17PurchaseCineverse Corp.
CNVS
CSO and President
30,000
0.1131%
$2.00$60,000+35.5%
Total: 843652
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.